Q4 2023 13F Holders as of 12/31/2023
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
3.12M
-
Number of holders
-
1
-
Total 13F shares, excl. options
-
2.96M
-
Shares change
-
+600K
-
Total reported value, excl. options
-
$2.99M
-
Value change
-
+$606K
-
Number of buys
-
1
-
Price
-
$1.01
Significant Holders of Passage BIO, Inc. - COMMON STOCK (PASG) as of Q4 2023
1 filings reported holding PASG - Passage BIO, Inc. - COMMON STOCK as of Q4 2023.
Passage BIO, Inc. - COMMON STOCK (PASG) has 1 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 2.96M shares
of 3.12M outstanding shares and own 94.99% of the company stock.
Largest 10 shareholders include ORBIMED ADVISORS LLC (10.1M shares), Versant Venture Management, LLC (4.96M shares), Erste Asset Management GmbH (2.96M shares), New Leaf Venture Partners, L.L.C. (2.5M shares), TANG CAPITAL MANAGEMENT LLC (2.4M shares), VANGUARD GROUP INC (2.02M shares), RENAISSANCE TECHNOLOGIES LLC (1.22M shares), BlackRock Inc. (1.02M shares), MILLENNIUM MANAGEMENT LLC (788K shares), and ACADIAN ASSET MANAGEMENT LLC (605K shares).
This table shows the top 1 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.